clinical trial · NCT01018342
Fed Study of Mylan Nitrofurantoin Monohydrate/Macrocrystals Capsules 100 mg and Macrobid® Capsules 100 mg
HealthyNitrofurantoin Monohydrate/Macrocrystals Capsules 100 mgMacrobid® Capsules 100 mg
brief summary
The objective of this study was to investigate the bioequivalence of Mylan nitrofurantoin monohydrate/macrocrystals capsules to Procter \& Gamble Macrobid® capsules following a single, oral 100 mg (1 x 100 mg) dose under fed conditions.
started
Jul 1, 2002
primary completion
Aug 1, 2002
completion
—
last updated
Apr 23, 2024
official title
Single-Dose Food In Vivo Bioequivalence Study of Mylan Nitrofurantoin Monohydrate/Macrocrystals Capsules (100 mg; Mylan) and Macrobid® Capsules (100 mg; Procter & Gamble) in Healthy Volunteers.
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol